Workflow
四环生物(000518) - 2025 Q1 - 季度财报
JSSHJSSH(SZ:000518)2025-04-29 08:20

Financial Performance - The company's revenue for Q1 2025 was ¥43,841,686.93, a decrease of 22.26% compared to ¥56,398,850.85 in the same period last year[5] - The net loss attributable to shareholders was ¥15,914,724.60, representing a significant increase of 436.35% from a loss of ¥2,967,209.29 in the previous year[5] - Total operating revenue decreased to ¥43,841,686.93 from ¥56,398,850.85, representing a decline of approximately 22.3% year-over-year[18] - Net loss attributable to the parent company was ¥15,914,724.60, compared to a loss of ¥2,967,209.29 in the previous period, indicating a significant increase in losses[19] - The total comprehensive loss for the period was ¥17,157,875.99, compared to a loss of ¥3,230,218.16 in the previous period, indicating a worsening financial position[19] Cash Flow - The net cash flow from operating activities increased by 79.70% to ¥9,726,780.20, up from ¥5,412,924.97 in the same period last year[5] - Operating cash inflow for the current period was CNY 63,053,484.57, an increase of 7.3% compared to CNY 58,767,005.15 in the previous period[20] - Cash received from other operating activities increased significantly to CNY 20,049,151.52 from CNY 1,991,272.43, marking a growth of over 900%[20] - The net increase in cash and cash equivalents was CNY 8,031,240.06, compared to a decrease of CNY 2,516,593.42 in the previous period[21] - The ending balance of cash and cash equivalents was CNY 16,025,481.15, up from CNY 12,697,043.58 in the prior period[21] Assets and Liabilities - Total assets at the end of the reporting period were ¥559,033,527.59, a decrease of 1.48% from ¥567,402,831.84 at the end of the previous year[5] - Total liabilities increased to ¥177,217,825.18 from ¥168,429,253.44, marking an increase of about 5.0%[17] - The company's total equity attributable to shareholders decreased by 4.28% to ¥355,798,555.07 from ¥371,713,279.67 at the end of the previous year[5] - The company's total equity decreased to ¥381,815,702.41 from ¥398,973,578.40, a decline of about 4.3%[17] Research and Development - Research and development expenses rose by 31.09% to ¥9,049,945.79, compared to ¥6,903,522.01 in the previous year, reflecting increased investment in R&D[8] - Research and development expenses rose to ¥9,049,945.79 from ¥6,903,522.01, an increase of approximately 31.0% year-over-year[18] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 102,819[10] - The largest shareholder, Fujian Bwater Agricultural Investment Co., Ltd., held 27.78% of the shares, totaling 28,599,000 shares[10] - The company completed the transfer of 28,599 million shares, accounting for 27.78% of the total share capital, to Fujian Bwater Agricultural Investment Co., Ltd. for CNY 387,573,648[12] Other Financial Metrics - The basic and diluted earnings per share were both -¥0.0155, a decline of 434.48% from -¥0.0029 in the same period last year[5] - The company reported a significant increase in credit impairment losses, amounting to -¥573,589.37 compared to -¥3,563,007.96 in the previous period[19] - Total operating costs increased to ¥57,812,555.10 from ¥56,979,130.03, reflecting an increase of about 1.5% year-over-year[18] Cash Management - Cash outflow for purchasing goods and services was CNY 11,520,397.74, an increase of 31.5% from CNY 8,782,504.20 in the previous period[20] - Cash outflow for financing activities was CNY 719,343.78, a significant decrease of 87.7% compared to CNY 5,845,862.07 in the prior period[21] - Total cash outflow for investment activities was CNY 976,196.36, down 53.7% from CNY 2,103,168.58 in the previous period[20] Audit Status - The first quarter report was not audited, indicating potential areas for further scrutiny in financial reporting[22]